Releaf Signs Historic Medical Cannabis Deal in the UK

Releaf, the UK's fastest-growing medical cannabis provider, has inked a multi-million-pound contract with Glass Pharms, marking the largest such agreement in the UK's medical cannabis sector to date. This deal underscores Releaf's market dominance and its rapid growth trajectory.

Under the partnership, Glass Pharms will supply 145kg of high-quality medical cannabis to Releaf, enhancing the latter's ability to meet growing demand while maintaining quality care. This aligns with Releaf's goal of expanding its patient base beyond the current UK market size of 45,000 patients within a year.

The collaboration with Glass Pharms ensures a reliable UK-based supply chain, addressing previous industry challenges related to prescription consistency. Additionally, it supports their shared commitment to sustainability, as Glass Pharms employs cutting-edge technologies and operates with a carbon-negative footprint.